Cabenuva
(cabotegravir and rilpivirine)
Cabenuva is a 2-drug co-packaged product of cabotegravir, a HIV-1 integrase strand transfer inhibitor (INSTI), and rilpivirine, an HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI).
Considerations for the Implementation of Cabenuva use in Clinical Practice
Administration of Cabenuva at Alternative Locations
Injection Education Video
Cabenuva Administration Instructions
Watch how to prepare and administer cabotegravir + rilpivirine.
Implementation Webinars and Podcasts
Bringing Long-Acting Injectables to the Clinic: Insights from Early Adopters
A discussion on best practices for long-acting injectable (LAI) HIV treatment and prevention in real-world settings. Hear insights from frontline HCPs on clinic workflows and strategies to overcome operational barriers and support appropriate patient access. ViiV Medical webinar with panel discussion and audience Q&A
Moving The Needle: Injecting Real-World Experience Into Long-Acting HIV Treatment And Prevention
A discussion on the mounting real-world evidence for long-acting injectable (LAI) treatment and prevention. Hear insights from HCPs on how to implement LAIs in clinical settings, including practical insights. ViiV Medical webinar with panel discussion and audience Q&A
The ABCs of CAB: Incorporating Long-Acting Cabenuva into Clinical Practice
A discussion of key considerations for incorporating long-acting Cabenuva into clinical practice, including patient selection, dosing strategies, and practical approaches to implementation in real-world settings. ViiV Medical webinar with panel discussion and audience Q&A
Cabenuva Conversations Podcast Series: Implementation Experiences
HCPs share their experiences implementing Cabenuva across different practice settings, highlighting diverse models of care.
For information on select publicly available resources to help providers implement CABENUVA into clinical practice, visit the following:
Learning Centers
For information regarding insurance coverage, reimbursement support, and affordability programs, ViiVConnect offers support resources to facilitate patient access to a prescribed ViiV Medication. ViiVConnect is funded by ViiV Healthcare.